Mohamed-Ali V - Search Results

1

Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study.

Kelberman D, Hawe E, Luong LA, Mohamed-Ali V, Lundman P, Tornvall P, Aillaud MF, Juhan-Vague I, Yudkin JS, Margaglione M, di Minno G, Tremoli E, Humphries SE; HIFMECH study group. Kelberman D, et al. Thromb Haemost. 2004 Nov;92(5):1122-8. doi: 10.1160/TH04-04-0202. Thromb Haemost. 2004. PMID: 15543342

2

Determinants of plasminogen activator inhibitor-1 activity in survivors of myocardial infarction.

Gray RP, Mohamed-Ali V, Patterson DL, Yudkin JS. Gray RP, et al. Thromb Haemost. 1995 Feb;73(2):261-7. Thromb Haemost. 1995. PMID: 7792741

3

Gene-environment interaction in the determination of levels of plasma fibrinogen.

Humphries SE, Luong LA, Montgomery HE, Day IN, Mohamed-Ali V, Yudkin JS. Humphries SE, et al. Thromb Haemost. 1999 Aug;82(2):818-25. Thromb Haemost. 1999. PMID: 10605788 Review. No abstract available.

4

Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study.

Yudkin JS, Juhan-Vague I, Hawe E, Humphries SE, di Minno G, Margaglione M, Tremoli E, Kooistra T, Morange PE, Lundman P, Mohamed-Ali V, Hamsten A; HIFMECH Study Group. Yudkin JS, et al. Metabolism. 2004 Jul;53(7):852-7. doi: 10.1016/j.metabol.2004.02.004. Metabolism. 2004. PMID: 15254876

5

Plasminogen activator inhibitor-1 (PAI-1) activity post myocardial infarction: the role of acute phase reactants, insulin-like molecules and promoter (4G/5G) polymorphism in the PAI-1 gene.

Panahloo A, Mohamed-Ali V, Gray RP, Humphries SE, Yudkin JS. Panahloo A, et al. Atherosclerosis. 2003 Jun;168(2):297-304. doi: 10.1016/s0021-9150(03)00095-9. Atherosclerosis. 2003. PMID: 12801613

6

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Yudkin JS, et al. Atherosclerosis. 2000 Feb;148(2):209-14. doi: 10.1016/s0021-9150(99)00463-3. Atherosclerosis. 2000. PMID: 10657556 Review.

7

Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.

Panahloo A, Mohamed-Ali V, Lane A, Green F, Humphries SE, Yudkin JS. Panahloo A, et al. Diabetes. 1995 Jan;44(1):37-42. doi: 10.2337/diab.44.1.37. Diabetes. 1995. PMID: 7813812 Clinical Trial.

8

Proinsulin-like molecules and plasminogen activator inhibitor type 1 (PAI-1) activity in diabetic and non-diabetic subjects with and without myocardial infarction.

Gray RP, Panahloo A, Mohamed-Ali V, Patterson DL, Yudkin JS. Gray RP, et al. Atherosclerosis. 1997 Apr;130(1-2):171-8. doi: 10.1016/s0021-9150(96)06070-4. Atherosclerosis. 1997. PMID: 9126661

9

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. Fishman D, et al. J Clin Invest. 1998 Oct 1;102(7):1369-76. doi: 10.1172/JCI2629. J Clin Invest. 1998. PMID: 9769329 Free PMC article.

10

The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance?

Panahloo A, Andrès C, Mohamed-Ali V, Gould MM, Talmud P, Humphries SE, Yudkin JS. Panahloo A, et al. Circulation. 1995 Dec 15;92(12):3390-3. doi: 10.1161/01.cir.92.12.3390. Circulation. 1995. PMID: 8521557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters